Deprecated: Creation of dynamic property cls_session::$session_data_table is deprecated in /www/sites/www.188bio.com/index/systems/cls_session.php on line 49
Xcessbio/SBI-0206965, Autophagy Kinase ULK1 Inhibitor-Xcessbio Biosciences Inc/2 mg solid/M60268-2s188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Xcessbio/SBI-0206965, Autophagy Kinase ULK1 Inhibitor-Xcessbio Biosciences Inc/2 mg solid/M60268-2s

Details
Product Information
Molecular Weight:489.33
Formula:C21H21BrN4O5
Purity:≥98%
CAS#:n/a
Solubility:DMSO up to 50 mM
Chemical Name:2-((5-bromo-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)oxy)-N-methylbenzamide
Storage:Powder:4oC 1 year. DMSO:4oC3 month;-20oC 1 year.

Biological Activity:SBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor. It inhibits ULK1 kinase with IC50 of 108 nM and the highly related kinase ULK2 with IC50 of 711 nM. It has very high selectivity, only inhibits 10 out of 456 kinases >95% when tested at 10 µM. SBI-0206965 suppressed ULK1-mediated phosphorylation events in cells, regulating autophagy and cell survival It can suppress autophagy induced by mTOR inhibition, prevent ULK1-dependent cell survival following nutrient deprivation. It greatly synergized with mechanistic target of rapamycin (mTOR) inhibitors to kill tumor cells, providing a strong rationale for their combined use in the clinic.How to Use:In vitro: SBI-0206965 was usually used at 10 µM final concentration in vitro.In vivo: n/aReference:

  • 1.Egan DF, et al. Small Molecule Inhibition of the Autophagy Kinase ULK1 and Identification of ULK1 Substrates. (2015) Mol Cell. 59(2):285-97.
SBI-0206965_spec.pdf
SBI-0206965_MSDS.pdf
Products are for research use only. Not for human use.

新闻动态
行业前沿
技术文章
最新产品